Originalartikel und Übersichtsarbeiten
Schreiber LS, Wozniak D, Scheller E, Böttcher E, Pelz JO, Schmidt FM. Enlarged cross-sectional area of the left vagus nerve in patients with major depressive disorder. Front Psychiatry. 2023;14:1237983.
Günther V, Kropidlowski A, Schmidt FM, Koelkebeck K, Kersting A, Suslow T. Attentional processes during emotional face perception in social anxiety disorder: A systematic review and meta-analysis of eye-tracking findings. Prog Neuropsychopharmacol Biol Psychiatry. 2021; 111: 110353.
Weil AS, Günther V, Schmidt FM, Kersting A, Quirin M, Suslow T. Criterion Validity of the Implicit Positive and Negative Affect Test: Prediction of Facial Affect Perception. Front Psychol. 2021; 12: 635368.
Dogan-Sander E, Mergl R, Willenberg A, Baber R, Wirkner K, Riedel-Heller SG, Röhr S, Schmidt FM, Schomerus G, Sander C. Inflammation and the Association of Vitamin D and Depressive Symptomatology. Nutrients 2021; 13: 1972.
Surova G, Ulke C, Schmidt FM, Hensch T, Sander C, Hegerl U. Eur Fatigue and brain arousal in patients with major depressive disorder. Arch Psychiatry Clin Neurosci. 2021; 271: 527-536.
Schmidt FM, Mergl R, Minkwitz J, Holdt LM, Teupser D, Hegerl U, Himmerich H, Sander C Is There an Association or Not?-Investigating the Association of Depressiveness, Physical Activity, Body Composition and Sleep With Mediators of Inflammation. Front Psychiatry 2020; 11: 563.
Minkwitz J, Sander C, Himmerich H, Thormann J, Chittka T, Hegerl U, Schmidt F, Murray M, Albayrak N, Campbell IC, Scheipl F. Reported and Recorded Sleepiness in Obesity and Depression. Front Psychiatry 2020; 11: 200.
Schmidt FM, Sander C, Walter M. Editorial: Recent Advances on the Multimodal Search for Markers of Treatment Response in Affective Disorders: From Bench to Bedside? Front Psychiatry 2019; 10: 790.
Schmidt FM, Koch J, Nowak C, Holdt LM, Teupser D, Hegerl U, Himmerich H. Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy. J Psychiatr Res. 2019; 119: 116-121.
Hartmann R, Schmidt FM, Sander C, Hegerl U. Heart Rate Variability as Indicator of Clinical State in Depression. Front Psychiatry 2019; 9: 735.
Schmidt FM, Sander C, Minkwitz J,Mergl R, Dalton B, Holdt LM,Teupser D, Hegerl U and Himmerich H.Serum Markers of Inflammation Mediate the Positive Association Between Neuroticism and Depression. Front. Psychiatry 2018; 9: 609.
Sander C, Schmidt JM, Mergl R, Schmidt FM, Hegerl U. Changes in brain arousal (EEG-vigilance) after therapeutic sleep deprivation in depressive patients and healthy controls. Sci Rep. 2018; 8: 15087.
Schmidt FM. Cognitive behaviour therapy and inflammation: A systematic review of its relationship and the potential implications for the treatment of depression. Aust N Z J Psychiatry 2018; 52: 385-386.
Schmidt FM, Sander C, Dietz ME, Nowak C, Schröder T, Mergl R, Schönknecht P, Himmerich H, Hegerl U. Brain arousal regulation as response predictor for antidepressant therapy in major depression’. Sci Rep 2017; 7: 45187.
Schmidt FM, Schindler S, Adamidis M, Strauß M, Tränkner A, Trampel R, Walter M, Hegerl U, Turner R, Geyer S, Schönknecht P. Habenula volume increases with disease severity in unmedicated major depressive disorder as revealed by 7T MRI. Eur Arch Psychiatry Clin Neurosci 2017; 267: 107-115.
Schmidt FM, Schröder T, Kirkby KC, Sander C, Suslow T, Holdt LM, Teupser D, Hegerl U, Himmerich H. Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression. Psychiatry Res 2016; 239: 85-91.
Schmidt FM, Pschiebl A, Sander C, Kirkby KC, Thormann J, Minkwitz J, Chittka T, Weschenfelder J, Holdt LM, Teupser D, Hegerl U, Himmerich H. Impact of Serum Cytokine Levels on EEG-Measured Arousal Regulation in Patients with Major Depressive Disorder and Healthy Controls. Neuropsychobiology 2016; 73: 1-9.
Schmidt FM, Kirkby KC, Lichtblau N. Inflammation and immune regulation as potential drug targets in antidepressant treatment. Curr Neuropharmacol 2016; 14: 674-87.
Schmidt FM, Nowak C, Kratzsch J, Sander C, Heger U, Schönknecht P. Melanin-concentrating hormone (MCH) in major depressive disorder during antidepressant therapy. J Affect Disorder 2015; 180:207-13.
Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, Mergl R, Kirkby KC, Faßhauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One 2015; 10: e0121971.
Schmidt FM, Steinberg H, Himmerich H. [Differential diagnosis of bipolar disorder: historical and clinical implications and perspectives]. Fortschr Neurol Psychiatr 2015; 83: 74-82.
Petersein C, Sack U, Mergl R, Schönherr J, Schmidt FM, Lichtblau N, Kirkby KC, Bauer K, Himmerich H. Impact of lithium alone and in combination with antidepressants on cytokine production in vitro. J Neural Transm 2015; 122: 109-22.
Schmidt FM, Mergl R, Stach B, Jahn I, Schönknecht P. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder. World J Biol Psychiatry 2015; 16: 106-13.
Schmidt FM, Kirkby KC, Himmerich H. The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases. Psychiatr Danub 2014; 26: 288-90.
Schmidt FM, Lichtblau N, Minkwitz J, Chittka T, Thormann J, Kirkby KC, Sander C, Mergl R, Faßhauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H. Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res 2014; 55: 29-34.
Schmidt FM, Mergl R, Stach B, Jahn I, Gertz HJ, Schönknecht P. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease. Neurosci Lett 2014; 570: 81-85.
Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H. Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry 2013; 25: 592-603.
Schmidt FM, Kratzsch J, Gertz H-J, Tittmann M, Jahn I, Pietsch UC, Kaisers UX, Thiery J, Hegerl U, Schönknecht P. Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer's Disease. PLOS ONE 2013; 8: e63136.
Schmidt FM, Schönherr J, Sander C, Kirkby KC, Hegerl U, Himmerich H. Applying EEG-based vigilance measurement in a case of adult attention deficit hyperactivity disorder. Int J Neuropsychopharmacol 2013; 16: 1169-71.
Schmidt FM, Lichtblau N, Uribe MM, Kirchherr H, Himmerich H. Agomelatine in breast milk. Int J Neuropsychopharmacol 2013; 16: 497-9.
Kern N, Sheldrick AJ, Schmidt FM, Minkwitz J. Neurobiology of depression and novel antidepressant drug targets. Curr Pharm Des 2012;18: 5791-801.
Schmidt FM, Tennert C, Teupser D, Himmerich H. Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression. Psychiatr Prax 2012; 39: 239-42.
Lichtblau N, Schmidt FM, Himmerich H. Die Rolle der Zytokine bei der Depression- Immunsystem und Depression. INFO Neurologie und Psychiatrie 2012; 14: 60-67.
Schmidt FM, Kratzsch J, Hegerl U, Schönknecht P. Die Rolle der Hypocretine in Affektiven Störungen. Nervenheilkunde 2011; 11: 893-897.
Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauss M, Baum P, Hegerl U, Schönknecht P. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Res 2011; 190: 240-3.
Schmidt FM, Brügel M, Kratzsch J, Strauss M, Sander C, Baum P, Thiery J, Hegerl U, Schönknecht P. Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neurosci Lett 2010; 483: 20-2.
Buchbeiträge
Schmidt FM. Mood stabilizers: Asenapine. NeuroPsychopharmacotherapy 2022. Riederer, Laux, Nagatsu, Le, Riederer. SpringerNature, 1. Auflage, ISBN 978-3-0-030-62058-5, doi: 10.1007/978-3-030-62059.
Section editor - Antipsychotics / Neuroleptics. NeuroPsychopharmacotherapy 2022. Riederer, Laux, Nagatsu, Le, Riederer. SpringerNature, 1. Auflage, ISBN 978-3-0-030-62058-5, doi: 10.1007/978-3-030-62059.